BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16638187)

  • 1. [Analysis of DEK-CAN fusion gene expression in acute myeloid leukemia patients with 6; 9 chromosome translocation].
    Wang YL; Wang T; Xu F; Gang Y; Wang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):232-6. PubMed ID: 16638187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical and laboratory study on acute myeloid leukemia with t(6;9)(p23;q34)].
    Wang Y; Xue Y; Chen S; Wu Y; Pan J; Zhang J; Shen J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):34-7. PubMed ID: 20140864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dek-can rearrangement in translocation (6;9)(p23;q34).
    Soekarman D; von Lindern M; van der Plas DC; Selleri L; Bartram CR; Martiat P; Culligan D; Padua RA; Hasper-Voogt KP; Hagemeijer A
    Leukemia; 1992 Jun; 6(6):489-94. PubMed ID: 1602786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.
    von Lindern M; Fornerod M; Soekarman N; van Baal S; Jaegle M; Hagemeijer A; Bootsma D; Grosveld G
    Baillieres Clin Haematol; 1992 Oct; 5(4):857-79. PubMed ID: 1308167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.
    Østergaard M; Stentoft J; Hokland P
    Leuk Res; 2004 Nov; 28(11):1213-5. PubMed ID: 15380347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript.
    Hamaguchi H; Nagata K; Yamamoto K; Fujikawa I; Kobayashi M; Eguchi M
    Br J Haematol; 1998 Sep; 102(5):1249-56. PubMed ID: 9753053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.
    von Lindern M; Fornerod M; van Baal S; Jaegle M; de Wit T; Buijs A; Grosveld G
    Mol Cell Biol; 1992 Apr; 12(4):1687-97. PubMed ID: 1549122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of relapse in DEK-NUP214-positive acute myeloid leukemia patients.
    Ommen HB; Touzart A; MacIntyre E; Kern W; Haferlach T; Haferlach C; Tobal K; Hokland P; Schnittger S
    Eur J Haematol; 2015 Nov; 95(5):436-41. PubMed ID: 25605311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
    Sandahl JD; Coenen EA; Forestier E; Harbott J; Johansson B; Kerndrup G; Adachi S; Auvrignon A; Beverloo HB; Cayuela JM; Chilton L; Fornerod M; de Haas V; Harrison CJ; Inaba H; Kaspers GJ; Liang DC; Locatelli F; Masetti R; Perot C; Raimondi SC; Reinhardt K; Tomizawa D; von Neuhoff N; Zecca M; Zwaan CM; van den Heuvel-Eibrink MM; Hasle H
    Haematologica; 2014 May; 99(5):865-72. PubMed ID: 24441146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.
    Fang H; Yabe M; Zhang X; Kim Y; Wu X; Wei P; Chi S; Zheng L; Garcia-Manero G; Shao L; Yuan J; Shen Y; Zheng G; Tang G; Wang W; Loghavi S; Shen Q; Yuan Y; He R; Chen D; Medeiros LJ; Hu S
    Mod Pathol; 2021 Jun; 34(6):1143-1152. PubMed ID: 33558656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report.
    Hao Q; Zhang Q; Li C; Wei S; Li Q; Song Y; Mi Y
    Oncol Lett; 2017 Dec; 14(6):7021-7024. PubMed ID: 29344131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a D-FISH method to detect DEK/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia.
    Shearer BM; Knudson RA; Flynn HC; Ketterling RP
    Leukemia; 2005 Jan; 19(1):126-31. PubMed ID: 15510206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia.
    von Lindern M; Breems D; van Baal S; Adriaansen H; Grosveld G
    Genes Chromosomes Cancer; 1992 Oct; 5(3):227-34. PubMed ID: 1384675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
    Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
    Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.
    Díaz-Beyá M; Labopin M; Maertens J; Aljurf M; Passweg J; Dietrich B; Schouten H; Socié G; Schaap N; Schwerdtfeger R; Volin L; Michallet M; Polge E; Sierra J; Mohty M; Esteve J; Nagler A;
    Br J Haematol; 2020 Jun; 189(5):920-925. PubMed ID: 32020596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
    Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Translocation t(6;9;8)(p23;q34;q22) in acute myeloid leukemia: Contribution of fluorescence in situ hybridization].
    van den Akker J; Pérot C; Portnoï MF; Philizot L; Dupont JM; Laporte JP; Taillemite JL
    Ann Genet; 1995; 38(3):168-71. PubMed ID: 8540689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation].
    Toyosawa M; Shinohara K; Ariyoshi K; Ando T; Kobayashi M; Hikiji K
    Rinsho Ketsueki; 1997 Jan; 38(1):33-40. PubMed ID: 9028159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
    Tobal K; Frost L; Liu Yin JA
    Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.